NUVB Relative Valuation
NUVB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NUVB is overvalued; if below, it's undervalued.
Historical Valuation
Nuvation Bio Inc (NUVB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -8.98. The fair price of Nuvation Bio Inc (NUVB) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：8.30
Fair
-14.27
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Nuvation Bio Inc. (NUVB) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-14.36
EV/EBIT
Nuvation Bio Inc. (NUVB) has a current EV/EBIT of -14.36. The 5-year average EV/EBIT is -3.30. The thresholds are as follows: Strongly Undervalued below -17.49, Undervalued between -17.49 and -10.40, Fairly Valued between 3.80 and -10.40, Overvalued between 3.80 and 10.90, and Strongly Overvalued above 10.90. The current Forward EV/EBIT of -14.36 falls within the Undervalued range.
19.31
PS
Nuvation Bio Inc. (NUVB) has a current PS of 19.31. The 5-year average PS is 45.41. The thresholds are as follows: Strongly Undervalued below -323.64, Undervalued between -323.64 and -139.12, Fairly Valued between 229.94 and -139.12, Overvalued between 229.94 and 414.46, and Strongly Overvalued above 414.46. The current Forward PS of 19.31 falls within the Historic Trend Line -Fairly Valued range.
-14.99
P/OCF
Nuvation Bio Inc. (NUVB) has a current P/OCF of -14.99. The 5-year average P/OCF is -9.26. The thresholds are as follows: Strongly Undervalued below -25.89, Undervalued between -25.89 and -17.58, Fairly Valued between -0.95 and -17.58, Overvalued between -0.95 and 7.37, and Strongly Overvalued above 7.37. The current Forward P/OCF of -14.99 falls within the Historic Trend Line -Fairly Valued range.
-19.64
P/FCF
Nuvation Bio Inc. (NUVB) has a current P/FCF of -19.64. The 5-year average P/FCF is -9.08. The thresholds are as follows: Strongly Undervalued below -46.40, Undervalued between -46.40 and -27.74, Fairly Valued between 9.58 and -27.74, Overvalued between 9.58 and 28.24, and Strongly Overvalued above 28.24. The current Forward P/FCF of -19.64 falls within the Historic Trend Line -Fairly Valued range.
Nuvation Bio Inc (NUVB) has a current Price-to-Book (P/B) ratio of 8.80. Compared to its 3-year average P/B ratio of 1.57 , the current P/B ratio is approximately 459.24% higher. Relative to its 5-year average P/B ratio of 1.50, the current P/B ratio is about 487.65% higher. Nuvation Bio Inc (NUVB) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -17.54%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -13.82% , the current FCF yield is about -100.00% lower.
8.74
P/B
Median3y
1.57
Median5y
1.50
-6.63
FCF Yield
Median3y
-17.54
Median5y
-13.82
Competitors Valuation Multiple
The average P/S ratio for NUVB's competitors is 0.00, providing a benchmark for relative valuation. Nuvation Bio Inc Corp (NUVB) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 1704.68%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NUVB increased by 212.41% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 727.00K to 13.12M.
The secondary factor is the Margin Expansion, contributed -92.50%to the performance.
Overall, the performance of NUVB in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Nuvation Bio Inc (NUVB) currently overvalued or undervalued?
What is Nuvation Bio Inc (NUVB) fair value?
How does NUVB's valuation metrics compare to the industry average?
What is the current P/B ratio for Nuvation Bio Inc (NUVB) as of Dec 05 2025?
What is the current FCF Yield for Nuvation Bio Inc (NUVB) as of Dec 05 2025?
What is the current Forward P/E ratio for Nuvation Bio Inc (NUVB) as of Dec 05 2025?